Beneficial effects of Enterococcus faecalis in hypercholesterolemic mice on cholesterol transportation and gut microbiota
- 20 February 2019
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 103 (7) , 3181-3191
Abstract
Hypercholesterolemia plays a critical role in the development of atherosclerosis and cardiovascular diseases. Many works have been reported that gut microbiota could affect hypercholesterolemia through cholesterol metabolism. However, the role of gut microbiota on cholesterol transportation remains unclear. In this study, 8-week-old C57BL/6J mice were fed with high-cholesterol diet to build the hypercholesterolemic mice. Then, the hypercholesterolemic mice got the oral administration of Enterococcus faecalis ATCC19433 at a dose of 109 CFU/mL/day or PBS with high-cholesterol diet for 4 weeks. Serum was collected to detect the concentration of total cholesterol (TC). Meanwhile, pathology, histology, real-time polymerase chain reaction, Western blot, and immunofluorescence were used to evaluate the expression of ABCG5 and ABCG8 in the liver and small intestine. We also analyzed the composition of gut microbiota through high-throughput sequencing method. Oral administration of E. faecalis ATCC19433 significantly decreased the concentration of serum cholesterol in hypercholesterolemic mice. Furthermore, E. faecalis ATCC19433 reduced the concentration of liver cholesterol and improved cholesterol by increasing the expression of ABCG5 and ABCG8. Moreover, oral administration of E. faecalis ATCC19433 modulated the composition of gut microbiota and increased the counts of Lactobacillus, Bifidobacterium, and Akkermansia. Our results showed that E. faecalis ATCC19433 could exert hypocholesterolemic effect on hypercholesterolemic mice by improving transporter ABCG5 and ABCG8. E. faecalis ATCC19433 maybe contribute to the transportation of cholesterol potentially and modulate the composition of gut microbiota.Keywords
Funding Information
- National Natural Science Foundation of China (11572064, 31771599)
- the National Key Technology R&D Program of China (2016YFC1102305, 2016YFC1101101)
- the Fundamental Research Funds for the Central Universities (106112017CDJZRPY0202, 106112017CDJPT230001, 106112017CDJXY230002)
This publication has 45 references indexed in Scilit:
- Gene expression analysis of the liver and skeletal muscle of psyllium-treated miceBritish Journal of Nutrition, 2012
- Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant MiceDiabetes, 2011
- Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic miceProceedings of the National Academy of Sciences, 2011
- The Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial CellsBioMed Research International, 2011
- Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout miceJournal of Lipid Research, 2010
- Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl‐deficient dietMolecular Nutrition & Food Research, 2010
- Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut MicrobiotaApplied and Environmental Microbiology, 2009
- Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind studyLipids in Health and Disease, 2009
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993